The downregulation of phosphopeptides in genes like ARID1A, EPRS, and ZC3HAV1 in the high relapse-risk breast cancer group offers critical insights into their roles as tumor suppressors and regulatory molecules. This evidence concerns the gene EPRS1 and neoplasm.